Antibodies

30 Aug 2007 Merck Serono to Reconsider Development of Matuzumab in Metastatic Colorectal Cancer Patients
30 Aug 2007 Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment
29 Aug 2007 Baxter and the Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients with Alzheimer's Disease
29 Aug 2007 XOMA Licenses Antibody Technology to Pfizer
25 Aug 2007 Phase II study of IMC-1121B for advanced renal cell cancer opens for patient enrollment
25 Aug 2007 Avastin approved in Europe for first-line treatment of patients with advanced lung cancer
25 Aug 2007 Genentech announces resubmission of supplemental Biologics License Application for Avastin in combination with Paclitaxel for first-line metastatic breast cancer
24 Aug 2007 Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated
23 Aug 2007 MedImmune's motavizumab reduced RSV hospitalizations by 83 percent among high-risk native American, full-term infants in placebo-controlled Phase 3 study
22 Aug 2007 YM BioSciences', European partner, Oncoscience AG, announces initiation of advanced nimotuzumab trials in adult glioma and pancreatic cancer
22 Aug 2007 Protox acquires research program from Medicenna
21 Aug 2007 Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
21 Aug 2007 PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
17 Aug 2007 Auxilium Pharmaceuticals, Inc. receives clearance to resume clinical trials for XIAFLEX(TM)
17 Aug 2007 Anadis to use its polyclonal antibodies for treatment
17 Aug 2007 Cell Therapeutics, Inc. (CTI) enters agreement to acquire lymphoma drug Zevalin(R) from Biogen Idec for sales and marketing in the United States
15 Aug 2007 Oncoscience AG, the european partner of YM BioSciences, announces completion of patient enrollment in phase III brain cancer trial of nimotuzab
11 Aug 2007 Roche files IND for second Genmab antibody
10 Aug 2007 Rilonacept (IL-1 Trap) granted FDA priority review for the treatment of CAPS
09 Aug 2007 ORENCIA(R) (abatacept) supplemental biologics license application for juvenile idiopathic arthritis accepted by FDA for filing and review
09 Aug 2007 InNexus Biotechnology unveils new platform for augmenting antibody therapeutics
08 Aug 2007 Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Enter into Agreement to Humanize Two Monoclonal Antibodies for the Treatment of Alzheimer's Disease
04 Aug 2007 Bayer HealthCare and Regeneron initiate Phase 3 global development program for VEGF Trap-Eye in wet age-related macular degeneration (AMD)
03 Aug 2007 Genmab regains rights to HuMax-TAC
03 Aug 2007 Macrogenics Begins Global Phase 2/3 Protege Study In Recent-onset Type 1 Diabetes Mellitus

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top